Methyl Aminolevulinate Hydrochloride Patent Expiration
Methyl Aminolevulinate Hydrochloride is Used for treating actinic keratoses using photodynamic therapy. It was first introduced by Galderma Laboratories Lp
Methyl Aminolevulinate Hydrochloride Patents
Given below is the list of patents protecting Methyl Aminolevulinate Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Metvixia | US6034267 | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar 08, 2016
(Expired) | Galderma Labs Lp |